Italia markets closed

SWAV May 2024 230.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,54000,0000 (0,00%)
In data: 11:08AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,5400
Aperto1,0000
Denaro0,0000
Domanda0,0500
Prezzo d'esercizio230,00
Scadenza2024-05-17
Min-Max giorno0,5400 - 1,0000
Contratto - Min-MaxN/D
Volume2
Open Interest4
  • GlobeNewswire

    Shockwave Medical to Livestream 2023 Investor Innovation Day

    SANTA CLARA, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, will host an Investor Innovation Day on Monday, October 23, 2023, from 1:00 p.m to 4:00 p.m. Pacific Time. The Shockwave Investor Innovation Day will be held in hybrid format, in person in San Francisco and online as a simultaneous live webcast. Investors and other interested

  • GlobeNewswire

    Shockwave Medical Appoints Nick West as Associate Chief Medical Officer

    Nick West, MD, joins Shockwave from Abbott VascularSANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer. Dr. West will report to Keith Dawkins, MD, Chief Medical Officer, and will be based in Santa Cl

  • GlobeNewswire

    Shockwave Medical Announces Dan Puckett to Retire as CFO in 2024

    SANTA CLARA, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Chief Financial Officer Dan Puckett plans to retire in the first quarter of 2024. Dan has served as the CFO at Shockwave since he joined the company in 2016. The Board of Directors has initiated a process to identify a successor. Mr. Puckett plans to con